Status:
RECRUITING
A Long Term Follow-up Study of TScan TCR-T Products
Lead Sponsor:
TScan Therapeutics, Inc.
Conditions:
AML
ALL
Eligibility:
All Genders
18-110 years
Brief Summary
The purpose of this Long-Term Follow-Up (LTFU) study is to monitor participants who have previously received TSC-100 or TSC-101 TCR-T therapies in the TSCAN-001 study. Participants will be monitored f...
Detailed Description
Participants will enroll in this LTFU study after completing the TSCAN-001 interventional trial. No additional study drug will be administered; however, participants may receive other cancer treatment...
Eligibility Criteria
Inclusion
- Participants who received a TCR-T cellular therapy in a clinical study sponsored by TScan Therapeutics.
- Signed informed consent.
Exclusion
- None
Key Trial Info
Start Date :
September 9 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2040
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06976736
Start Date
September 9 2025
End Date
September 1 2040
Last Update
September 10 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
City of Hope
Duarte, California, United States, 91010
2
Mount Sinai
New York, New York, United States, 10029-6696